Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    - The page revision updated from v3.2.0 to v3.3.2. No study content or data appears to be changed.
    Difference
    0.1%
    Check dated 2025-11-25T10:23:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding-status banner at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-18T06:47:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    No additions or deletions to core Study Details content were detected for NCT02041260. The page’s primary information, including eligibility criteria and trial details, remains unchanged.
    Difference
    0.5%
    Check dated 2025-11-03T20:38:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and a new software version (v3.2.0) replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T04:57:50.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T02:57:59.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T19:02:24.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.